nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—ABCG2—Vandetanib—thyroid cancer	0.238	0.431	CbGbCtD
Sumatriptan—ABCG2—Sorafenib—thyroid cancer	0.144	0.26	CbGbCtD
Sumatriptan—ABCG2—Doxorubicin—thyroid cancer	0.0872	0.158	CbGbCtD
Sumatriptan—ABCB1—Sorafenib—thyroid cancer	0.0518	0.0938	CbGbCtD
Sumatriptan—ABCB1—Doxorubicin—thyroid cancer	0.0314	0.0569	CbGbCtD
Sumatriptan—Melaena—Doxorubicin—thyroid cancer	0.000536	0.00131	CcSEcCtD
Sumatriptan—Rash—Vandetanib—thyroid cancer	0.000536	0.00131	CcSEcCtD
Sumatriptan—Dermatitis—Vandetanib—thyroid cancer	0.000535	0.0013	CcSEcCtD
Sumatriptan—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.000533	0.0013	CcSEcCtD
Sumatriptan—Headache—Vandetanib—thyroid cancer	0.000532	0.0013	CcSEcCtD
Sumatriptan—Cystitis—Doxorubicin—thyroid cancer	0.00053	0.00129	CcSEcCtD
Sumatriptan—Colitis—Doxorubicin—thyroid cancer	0.000527	0.00129	CcSEcCtD
Sumatriptan—Skin exfoliation—Doxorubicin—thyroid cancer	0.000524	0.00128	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000522	0.00127	CcSEcCtD
Sumatriptan—Fluid retention—Doxorubicin—thyroid cancer	0.000521	0.00127	CcSEcCtD
Sumatriptan—Dyspnoea—Sorafenib—thyroid cancer	0.000511	0.00125	CcSEcCtD
Sumatriptan—Lymphadenopathy—Epirubicin—thyroid cancer	0.000505	0.00123	CcSEcCtD
Sumatriptan—Nausea—Vandetanib—thyroid cancer	0.000505	0.00123	CcSEcCtD
Sumatriptan—Phlebitis—Epirubicin—thyroid cancer	0.0005	0.00122	CcSEcCtD
Sumatriptan—Decreased appetite—Sorafenib—thyroid cancer	0.000498	0.00121	CcSEcCtD
Sumatriptan—Thrombophlebitis—Epirubicin—thyroid cancer	0.000498	0.00121	CcSEcCtD
Sumatriptan—Bladder pain—Doxorubicin—thyroid cancer	0.000497	0.00121	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000495	0.00121	CcSEcCtD
Sumatriptan—Fatigue—Sorafenib—thyroid cancer	0.000494	0.0012	CcSEcCtD
Sumatriptan—Photosensitivity—Epirubicin—thyroid cancer	0.000491	0.0012	CcSEcCtD
Sumatriptan—Pain—Sorafenib—thyroid cancer	0.00049	0.00119	CcSEcCtD
Sumatriptan—Constipation—Sorafenib—thyroid cancer	0.00049	0.00119	CcSEcCtD
Sumatriptan—Eczema—Epirubicin—thyroid cancer	0.000479	0.00117	CcSEcCtD
Sumatriptan—Eye pain—Epirubicin—thyroid cancer	0.000477	0.00116	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000469	0.00114	CcSEcCtD
Sumatriptan—Lymphadenopathy—Doxorubicin—thyroid cancer	0.000467	0.00114	CcSEcCtD
Sumatriptan—Renal failure acute—Epirubicin—thyroid cancer	0.000467	0.00114	CcSEcCtD
Sumatriptan—Phlebitis—Doxorubicin—thyroid cancer	0.000463	0.00113	CcSEcCtD
Sumatriptan—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000461	0.00112	CcSEcCtD
Sumatriptan—Urticaria—Sorafenib—thyroid cancer	0.000455	0.00111	CcSEcCtD
Sumatriptan—Photosensitivity—Doxorubicin—thyroid cancer	0.000454	0.00111	CcSEcCtD
Sumatriptan—Abdominal pain—Sorafenib—thyroid cancer	0.000453	0.0011	CcSEcCtD
Sumatriptan—Body temperature increased—Sorafenib—thyroid cancer	0.000453	0.0011	CcSEcCtD
Sumatriptan—Dermatitis bullous—Epirubicin—thyroid cancer	0.000451	0.0011	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000445	0.00109	CcSEcCtD
Sumatriptan—Eczema—Doxorubicin—thyroid cancer	0.000444	0.00108	CcSEcCtD
Sumatriptan—Eye pain—Doxorubicin—thyroid cancer	0.000442	0.00108	CcSEcCtD
Sumatriptan—Hypoglycaemia—Epirubicin—thyroid cancer	0.000441	0.00108	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00044	0.00107	CcSEcCtD
Sumatriptan—Renal failure acute—Doxorubicin—thyroid cancer	0.000432	0.00105	CcSEcCtD
Sumatriptan—Osteoarthritis—Epirubicin—thyroid cancer	0.000431	0.00105	CcSEcCtD
Sumatriptan—Diplopia—Epirubicin—thyroid cancer	0.000431	0.00105	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000431	0.00105	CcSEcCtD
Sumatriptan—Migraine—Epirubicin—thyroid cancer	0.000424	0.00103	CcSEcCtD
Sumatriptan—Hypersensitivity—Sorafenib—thyroid cancer	0.000422	0.00103	CcSEcCtD
Sumatriptan—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000417	0.00102	CcSEcCtD
Sumatriptan—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000412	0.001	CcSEcCtD
Sumatriptan—Asthenia—Sorafenib—thyroid cancer	0.000411	0.001	CcSEcCtD
Sumatriptan—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000408	0.000996	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000407	0.000992	CcSEcCtD
Sumatriptan—Pruritus—Sorafenib—thyroid cancer	0.000405	0.000988	CcSEcCtD
Sumatriptan—Dehydration—Epirubicin—thyroid cancer	0.000401	0.000977	CcSEcCtD
Sumatriptan—Osteoarthritis—Doxorubicin—thyroid cancer	0.000399	0.000972	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000399	0.000972	CcSEcCtD
Sumatriptan—Diplopia—Doxorubicin—thyroid cancer	0.000399	0.000972	CcSEcCtD
Sumatriptan—Liver function test abnormal—Epirubicin—thyroid cancer	0.000398	0.00097	CcSEcCtD
Sumatriptan—Migraine—Doxorubicin—thyroid cancer	0.000392	0.000957	CcSEcCtD
Sumatriptan—Diarrhoea—Sorafenib—thyroid cancer	0.000392	0.000956	CcSEcCtD
Sumatriptan—Gastritis—Epirubicin—thyroid cancer	0.000381	0.00093	CcSEcCtD
Sumatriptan—Dizziness—Sorafenib—thyroid cancer	0.000379	0.000924	CcSEcCtD
Sumatriptan—Abdominal distension—Epirubicin—thyroid cancer	0.000375	0.000914	CcSEcCtD
Sumatriptan—Influenza—Epirubicin—thyroid cancer	0.000372	0.000908	CcSEcCtD
Sumatriptan—Asthma—Epirubicin—thyroid cancer	0.000372	0.000908	CcSEcCtD
Sumatriptan—Dysphagia—Epirubicin—thyroid cancer	0.000372	0.000908	CcSEcCtD
Sumatriptan—Dehydration—Doxorubicin—thyroid cancer	0.000371	0.000904	CcSEcCtD
Sumatriptan—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000368	0.000897	CcSEcCtD
Sumatriptan—Pancreatitis—Epirubicin—thyroid cancer	0.000365	0.00089	CcSEcCtD
Sumatriptan—Vomiting—Sorafenib—thyroid cancer	0.000364	0.000888	CcSEcCtD
Sumatriptan—Angina pectoris—Epirubicin—thyroid cancer	0.000363	0.000884	CcSEcCtD
Sumatriptan—Rash—Sorafenib—thyroid cancer	0.000361	0.000881	CcSEcCtD
Sumatriptan—Dermatitis—Sorafenib—thyroid cancer	0.000361	0.00088	CcSEcCtD
Sumatriptan—Headache—Sorafenib—thyroid cancer	0.000359	0.000875	CcSEcCtD
Sumatriptan—Bronchitis—Epirubicin—thyroid cancer	0.000358	0.000873	CcSEcCtD
Sumatriptan—Pancytopenia—Epirubicin—thyroid cancer	0.000354	0.000862	CcSEcCtD
Sumatriptan—Gastritis—Doxorubicin—thyroid cancer	0.000353	0.00086	CcSEcCtD
Sumatriptan—Dysuria—Epirubicin—thyroid cancer	0.000348	0.000849	CcSEcCtD
Sumatriptan—Abdominal distension—Doxorubicin—thyroid cancer	0.000347	0.000846	CcSEcCtD
Sumatriptan—Dysphagia—Doxorubicin—thyroid cancer	0.000345	0.00084	CcSEcCtD
Sumatriptan—Asthma—Doxorubicin—thyroid cancer	0.000345	0.00084	CcSEcCtD
Sumatriptan—Influenza—Doxorubicin—thyroid cancer	0.000345	0.00084	CcSEcCtD
Sumatriptan—Pollakiuria—Epirubicin—thyroid cancer	0.000344	0.000839	CcSEcCtD
Sumatriptan—Nausea—Sorafenib—thyroid cancer	0.00034	0.00083	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00034	0.000829	CcSEcCtD
Sumatriptan—Weight increased—Epirubicin—thyroid cancer	0.000339	0.000826	CcSEcCtD
Sumatriptan—Pancreatitis—Doxorubicin—thyroid cancer	0.000338	0.000824	CcSEcCtD
Sumatriptan—Weight decreased—Epirubicin—thyroid cancer	0.000337	0.000821	CcSEcCtD
Sumatriptan—Hyperglycaemia—Epirubicin—thyroid cancer	0.000336	0.000819	CcSEcCtD
Sumatriptan—Angina pectoris—Doxorubicin—thyroid cancer	0.000336	0.000818	CcSEcCtD
Sumatriptan—Drowsiness—Epirubicin—thyroid cancer	0.000332	0.000809	CcSEcCtD
Sumatriptan—Bronchitis—Doxorubicin—thyroid cancer	0.000331	0.000808	CcSEcCtD
Sumatriptan—Pancytopenia—Doxorubicin—thyroid cancer	0.000327	0.000798	CcSEcCtD
Sumatriptan—Conjunctivitis—Epirubicin—thyroid cancer	0.000323	0.000787	CcSEcCtD
Sumatriptan—Dysuria—Doxorubicin—thyroid cancer	0.000322	0.000786	CcSEcCtD
Sumatriptan—Sweating—Epirubicin—thyroid cancer	0.000318	0.000776	CcSEcCtD
Sumatriptan—Pollakiuria—Doxorubicin—thyroid cancer	0.000318	0.000776	CcSEcCtD
Sumatriptan—Haematuria—Epirubicin—thyroid cancer	0.000317	0.000772	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000314	0.000767	CcSEcCtD
Sumatriptan—Weight increased—Doxorubicin—thyroid cancer	0.000314	0.000764	CcSEcCtD
Sumatriptan—Epistaxis—Epirubicin—thyroid cancer	0.000313	0.000764	CcSEcCtD
Sumatriptan—Weight decreased—Doxorubicin—thyroid cancer	0.000312	0.00076	CcSEcCtD
Sumatriptan—Sinusitis—Epirubicin—thyroid cancer	0.000311	0.000759	CcSEcCtD
Sumatriptan—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000311	0.000758	CcSEcCtD
Sumatriptan—Drowsiness—Doxorubicin—thyroid cancer	0.000307	0.000749	CcSEcCtD
Sumatriptan—Bradycardia—Epirubicin—thyroid cancer	0.000303	0.00074	CcSEcCtD
Sumatriptan—Haemoglobin—Epirubicin—thyroid cancer	0.0003	0.00073	CcSEcCtD
Sumatriptan—Conjunctivitis—Doxorubicin—thyroid cancer	0.000299	0.000728	CcSEcCtD
Sumatriptan—Haemorrhage—Epirubicin—thyroid cancer	0.000298	0.000727	CcSEcCtD
Sumatriptan—Hypoaesthesia—Epirubicin—thyroid cancer	0.000297	0.000723	CcSEcCtD
Sumatriptan—Sweating—Doxorubicin—thyroid cancer	0.000295	0.000718	CcSEcCtD
Sumatriptan—Haematuria—Doxorubicin—thyroid cancer	0.000293	0.000714	CcSEcCtD
Sumatriptan—Connective tissue disorder—Epirubicin—thyroid cancer	0.000293	0.000714	CcSEcCtD
Sumatriptan—Epistaxis—Doxorubicin—thyroid cancer	0.00029	0.000706	CcSEcCtD
Sumatriptan—Sinusitis—Doxorubicin—thyroid cancer	0.000288	0.000703	CcSEcCtD
Sumatriptan—Visual impairment—Epirubicin—thyroid cancer	0.000287	0.0007	CcSEcCtD
Sumatriptan—Bradycardia—Doxorubicin—thyroid cancer	0.000281	0.000684	CcSEcCtD
Sumatriptan—Eye disorder—Epirubicin—thyroid cancer	0.000279	0.000679	CcSEcCtD
Sumatriptan—Tinnitus—Epirubicin—thyroid cancer	0.000278	0.000678	CcSEcCtD
Sumatriptan—Haemoglobin—Doxorubicin—thyroid cancer	0.000277	0.000676	CcSEcCtD
Sumatriptan—Flushing—Epirubicin—thyroid cancer	0.000277	0.000674	CcSEcCtD
Sumatriptan—Haemorrhage—Doxorubicin—thyroid cancer	0.000276	0.000672	CcSEcCtD
Sumatriptan—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000274	0.000669	CcSEcCtD
Sumatriptan—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000271	0.000661	CcSEcCtD
Sumatriptan—Angiopathy—Epirubicin—thyroid cancer	0.00027	0.000659	CcSEcCtD
Sumatriptan—Immune system disorder—Epirubicin—thyroid cancer	0.000269	0.000656	CcSEcCtD
Sumatriptan—Mediastinal disorder—Epirubicin—thyroid cancer	0.000269	0.000655	CcSEcCtD
Sumatriptan—Chills—Epirubicin—thyroid cancer	0.000267	0.000652	CcSEcCtD
Sumatriptan—Arrhythmia—Epirubicin—thyroid cancer	0.000266	0.000649	CcSEcCtD
Sumatriptan—Visual impairment—Doxorubicin—thyroid cancer	0.000266	0.000648	CcSEcCtD
Sumatriptan—Erythema—Epirubicin—thyroid cancer	0.000259	0.000633	CcSEcCtD
Sumatriptan—Eye disorder—Doxorubicin—thyroid cancer	0.000258	0.000628	CcSEcCtD
Sumatriptan—Tinnitus—Doxorubicin—thyroid cancer	0.000257	0.000627	CcSEcCtD
Sumatriptan—Flushing—Doxorubicin—thyroid cancer	0.000256	0.000624	CcSEcCtD
Sumatriptan—Flatulence—Epirubicin—thyroid cancer	0.000256	0.000623	CcSEcCtD
Sumatriptan—Dysgeusia—Epirubicin—thyroid cancer	0.000254	0.000619	CcSEcCtD
Sumatriptan—Back pain—Epirubicin—thyroid cancer	0.000251	0.000612	CcSEcCtD
Sumatriptan—Angiopathy—Doxorubicin—thyroid cancer	0.00025	0.00061	CcSEcCtD
Sumatriptan—Muscle spasms—Epirubicin—thyroid cancer	0.000249	0.000608	CcSEcCtD
Sumatriptan—Immune system disorder—Doxorubicin—thyroid cancer	0.000249	0.000607	CcSEcCtD
Sumatriptan—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000249	0.000606	CcSEcCtD
Sumatriptan—Chills—Doxorubicin—thyroid cancer	0.000247	0.000603	CcSEcCtD
Sumatriptan—Arrhythmia—Doxorubicin—thyroid cancer	0.000246	0.000601	CcSEcCtD
Sumatriptan—Ill-defined disorder—Epirubicin—thyroid cancer	0.000241	0.000587	CcSEcCtD
Sumatriptan—Erythema—Doxorubicin—thyroid cancer	0.00024	0.000585	CcSEcCtD
Sumatriptan—Anaemia—Epirubicin—thyroid cancer	0.00024	0.000585	CcSEcCtD
Sumatriptan—Agitation—Epirubicin—thyroid cancer	0.000238	0.000581	CcSEcCtD
Sumatriptan—Flatulence—Doxorubicin—thyroid cancer	0.000237	0.000577	CcSEcCtD
Sumatriptan—Dysgeusia—Doxorubicin—thyroid cancer	0.000235	0.000573	CcSEcCtD
Sumatriptan—Malaise—Epirubicin—thyroid cancer	0.000234	0.00057	CcSEcCtD
Sumatriptan—Vertigo—Epirubicin—thyroid cancer	0.000233	0.000568	CcSEcCtD
Sumatriptan—Syncope—Epirubicin—thyroid cancer	0.000233	0.000567	CcSEcCtD
Sumatriptan—Back pain—Doxorubicin—thyroid cancer	0.000232	0.000566	CcSEcCtD
Sumatriptan—Muscle spasms—Doxorubicin—thyroid cancer	0.000231	0.000563	CcSEcCtD
Sumatriptan—Palpitations—Epirubicin—thyroid cancer	0.000229	0.000559	CcSEcCtD
Sumatriptan—Loss of consciousness—Epirubicin—thyroid cancer	0.000228	0.000556	CcSEcCtD
Sumatriptan—Cough—Epirubicin—thyroid cancer	0.000226	0.000552	CcSEcCtD
Sumatriptan—Convulsion—Epirubicin—thyroid cancer	0.000225	0.000548	CcSEcCtD
Sumatriptan—Hypertension—Epirubicin—thyroid cancer	0.000224	0.000546	CcSEcCtD
Sumatriptan—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000223	0.000543	CcSEcCtD
Sumatriptan—Anaemia—Doxorubicin—thyroid cancer	0.000222	0.000541	CcSEcCtD
Sumatriptan—Myalgia—Epirubicin—thyroid cancer	0.000221	0.000539	CcSEcCtD
Sumatriptan—Chest pain—Epirubicin—thyroid cancer	0.000221	0.000539	CcSEcCtD
Sumatriptan—Arthralgia—Epirubicin—thyroid cancer	0.000221	0.000539	CcSEcCtD
Sumatriptan—Agitation—Doxorubicin—thyroid cancer	0.000221	0.000538	CcSEcCtD
Sumatriptan—Anxiety—Epirubicin—thyroid cancer	0.00022	0.000537	CcSEcCtD
Sumatriptan—Discomfort—Epirubicin—thyroid cancer	0.000218	0.000532	CcSEcCtD
Sumatriptan—Malaise—Doxorubicin—thyroid cancer	0.000216	0.000528	CcSEcCtD
Sumatriptan—Dry mouth—Epirubicin—thyroid cancer	0.000216	0.000527	CcSEcCtD
Sumatriptan—Vertigo—Doxorubicin—thyroid cancer	0.000216	0.000526	CcSEcCtD
Sumatriptan—Syncope—Doxorubicin—thyroid cancer	0.000215	0.000525	CcSEcCtD
Sumatriptan—Confusional state—Epirubicin—thyroid cancer	0.000214	0.000521	CcSEcCtD
Sumatriptan—Palpitations—Doxorubicin—thyroid cancer	0.000212	0.000517	CcSEcCtD
Sumatriptan—Anaphylactic shock—Epirubicin—thyroid cancer	0.000212	0.000516	CcSEcCtD
Sumatriptan—Oedema—Epirubicin—thyroid cancer	0.000212	0.000516	CcSEcCtD
Sumatriptan—Loss of consciousness—Doxorubicin—thyroid cancer	0.000211	0.000514	CcSEcCtD
Sumatriptan—Infection—Epirubicin—thyroid cancer	0.00021	0.000513	CcSEcCtD
Sumatriptan—Cough—Doxorubicin—thyroid cancer	0.000209	0.000511	CcSEcCtD
Sumatriptan—Shock—Epirubicin—thyroid cancer	0.000208	0.000508	CcSEcCtD
Sumatriptan—Convulsion—Doxorubicin—thyroid cancer	0.000208	0.000507	CcSEcCtD
Sumatriptan—Nervous system disorder—Epirubicin—thyroid cancer	0.000208	0.000506	CcSEcCtD
Sumatriptan—Thrombocytopenia—Epirubicin—thyroid cancer	0.000207	0.000505	CcSEcCtD
Sumatriptan—Hypertension—Doxorubicin—thyroid cancer	0.000207	0.000505	CcSEcCtD
Sumatriptan—Tachycardia—Epirubicin—thyroid cancer	0.000207	0.000504	CcSEcCtD
Sumatriptan—Skin disorder—Epirubicin—thyroid cancer	0.000206	0.000501	CcSEcCtD
Sumatriptan—Hyperhidrosis—Epirubicin—thyroid cancer	0.000205	0.000499	CcSEcCtD
Sumatriptan—Myalgia—Doxorubicin—thyroid cancer	0.000204	0.000498	CcSEcCtD
Sumatriptan—Chest pain—Doxorubicin—thyroid cancer	0.000204	0.000498	CcSEcCtD
Sumatriptan—Arthralgia—Doxorubicin—thyroid cancer	0.000204	0.000498	CcSEcCtD
Sumatriptan—Anxiety—Doxorubicin—thyroid cancer	0.000204	0.000497	CcSEcCtD
Sumatriptan—Discomfort—Doxorubicin—thyroid cancer	0.000202	0.000492	CcSEcCtD
Sumatriptan—Dry mouth—Doxorubicin—thyroid cancer	0.0002	0.000487	CcSEcCtD
Sumatriptan—Hypotension—Epirubicin—thyroid cancer	0.000198	0.000482	CcSEcCtD
Sumatriptan—Confusional state—Doxorubicin—thyroid cancer	0.000198	0.000482	CcSEcCtD
Sumatriptan—Oedema—Doxorubicin—thyroid cancer	0.000196	0.000478	CcSEcCtD
Sumatriptan—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000196	0.000478	CcSEcCtD
Sumatriptan—Infection—Doxorubicin—thyroid cancer	0.000195	0.000475	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000193	0.00047	CcSEcCtD
Sumatriptan—Shock—Doxorubicin—thyroid cancer	0.000193	0.00047	CcSEcCtD
Sumatriptan—Nervous system disorder—Doxorubicin—thyroid cancer	0.000192	0.000468	CcSEcCtD
Sumatriptan—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000192	0.000468	CcSEcCtD
Sumatriptan—Tachycardia—Doxorubicin—thyroid cancer	0.000191	0.000466	CcSEcCtD
Sumatriptan—Skin disorder—Doxorubicin—thyroid cancer	0.00019	0.000464	CcSEcCtD
Sumatriptan—Paraesthesia—Epirubicin—thyroid cancer	0.00019	0.000464	CcSEcCtD
Sumatriptan—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000189	0.000462	CcSEcCtD
Sumatriptan—Dyspnoea—Epirubicin—thyroid cancer	0.000189	0.00046	CcSEcCtD
Sumatriptan—Somnolence—Epirubicin—thyroid cancer	0.000188	0.000459	CcSEcCtD
Sumatriptan—Decreased appetite—Epirubicin—thyroid cancer	0.000184	0.000449	CcSEcCtD
Sumatriptan—Hypotension—Doxorubicin—thyroid cancer	0.000183	0.000446	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000183	0.000446	CcSEcCtD
Sumatriptan—Fatigue—Epirubicin—thyroid cancer	0.000183	0.000445	CcSEcCtD
Sumatriptan—Constipation—Epirubicin—thyroid cancer	0.000181	0.000441	CcSEcCtD
Sumatriptan—Pain—Epirubicin—thyroid cancer	0.000181	0.000441	CcSEcCtD
Sumatriptan—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000179	0.000435	CcSEcCtD
Sumatriptan—Paraesthesia—Doxorubicin—thyroid cancer	0.000176	0.000429	CcSEcCtD
Sumatriptan—Dyspnoea—Doxorubicin—thyroid cancer	0.000175	0.000426	CcSEcCtD
Sumatriptan—Feeling abnormal—Epirubicin—thyroid cancer	0.000174	0.000425	CcSEcCtD
Sumatriptan—Somnolence—Doxorubicin—thyroid cancer	0.000174	0.000425	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000173	0.000422	CcSEcCtD
Sumatriptan—Decreased appetite—Doxorubicin—thyroid cancer	0.00017	0.000415	CcSEcCtD
Sumatriptan—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000169	0.000412	CcSEcCtD
Sumatriptan—Fatigue—Doxorubicin—thyroid cancer	0.000169	0.000412	CcSEcCtD
Sumatriptan—Urticaria—Epirubicin—thyroid cancer	0.000168	0.00041	CcSEcCtD
Sumatriptan—Constipation—Doxorubicin—thyroid cancer	0.000168	0.000408	CcSEcCtD
Sumatriptan—Pain—Doxorubicin—thyroid cancer	0.000168	0.000408	CcSEcCtD
Sumatriptan—Abdominal pain—Epirubicin—thyroid cancer	0.000167	0.000408	CcSEcCtD
Sumatriptan—Body temperature increased—Epirubicin—thyroid cancer	0.000167	0.000408	CcSEcCtD
Sumatriptan—Feeling abnormal—Doxorubicin—thyroid cancer	0.000161	0.000394	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00016	0.000391	CcSEcCtD
Sumatriptan—Hypersensitivity—Epirubicin—thyroid cancer	0.000156	0.00038	CcSEcCtD
Sumatriptan—Urticaria—Doxorubicin—thyroid cancer	0.000156	0.000379	CcSEcCtD
Sumatriptan—Abdominal pain—Doxorubicin—thyroid cancer	0.000155	0.000378	CcSEcCtD
Sumatriptan—Body temperature increased—Doxorubicin—thyroid cancer	0.000155	0.000378	CcSEcCtD
Sumatriptan—Asthenia—Epirubicin—thyroid cancer	0.000152	0.00037	CcSEcCtD
Sumatriptan—Pruritus—Epirubicin—thyroid cancer	0.00015	0.000365	CcSEcCtD
Sumatriptan—Diarrhoea—Epirubicin—thyroid cancer	0.000145	0.000353	CcSEcCtD
Sumatriptan—Hypersensitivity—Doxorubicin—thyroid cancer	0.000144	0.000352	CcSEcCtD
Sumatriptan—Asthenia—Doxorubicin—thyroid cancer	0.000141	0.000343	CcSEcCtD
Sumatriptan—Dizziness—Epirubicin—thyroid cancer	0.00014	0.000341	CcSEcCtD
Sumatriptan—Pruritus—Doxorubicin—thyroid cancer	0.000139	0.000338	CcSEcCtD
Sumatriptan—Vomiting—Epirubicin—thyroid cancer	0.000135	0.000328	CcSEcCtD
Sumatriptan—Diarrhoea—Doxorubicin—thyroid cancer	0.000134	0.000327	CcSEcCtD
Sumatriptan—Rash—Epirubicin—thyroid cancer	0.000134	0.000326	CcSEcCtD
Sumatriptan—Dermatitis—Epirubicin—thyroid cancer	0.000133	0.000325	CcSEcCtD
Sumatriptan—Headache—Epirubicin—thyroid cancer	0.000133	0.000323	CcSEcCtD
Sumatriptan—Dizziness—Doxorubicin—thyroid cancer	0.00013	0.000316	CcSEcCtD
Sumatriptan—Nausea—Epirubicin—thyroid cancer	0.000126	0.000307	CcSEcCtD
Sumatriptan—Vomiting—Doxorubicin—thyroid cancer	0.000125	0.000304	CcSEcCtD
Sumatriptan—Rash—Doxorubicin—thyroid cancer	0.000124	0.000301	CcSEcCtD
Sumatriptan—Dermatitis—Doxorubicin—thyroid cancer	0.000123	0.000301	CcSEcCtD
Sumatriptan—Headache—Doxorubicin—thyroid cancer	0.000123	0.000299	CcSEcCtD
Sumatriptan—Nausea—Doxorubicin—thyroid cancer	0.000116	0.000284	CcSEcCtD
Sumatriptan—ABCG2—Metabolism—CHST14—thyroid cancer	8.41e-05	0.00226	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	8.31e-05	0.00223	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	8.31e-05	0.00223	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—SST—thyroid cancer	8.31e-05	0.00223	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	8.18e-05	0.00219	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TSHR—thyroid cancer	8.1e-05	0.00217	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—CALCA—thyroid cancer	8e-05	0.00215	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—PTCH1—thyroid cancer	7.98e-05	0.00214	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—HPGD—thyroid cancer	7.94e-05	0.00213	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—TSHR—thyroid cancer	7.93e-05	0.00213	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.86e-05	0.00211	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—CDK1—thyroid cancer	7.79e-05	0.00209	CbGpPWpGaD
Sumatriptan—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	7.69e-05	0.00206	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TSHR—thyroid cancer	7.35e-05	0.00197	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—HPGD—thyroid cancer	7.32e-05	0.00196	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—SST—thyroid cancer	7.3e-05	0.00196	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PRKAR1A—thyroid cancer	7.23e-05	0.00194	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TSHR—thyroid cancer	7.2e-05	0.00193	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	7.12e-05	0.00191	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PRKAR1A—thyroid cancer	7.08e-05	0.0019	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—CALCA—thyroid cancer	7.02e-05	0.00188	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—BRAF—thyroid cancer	7e-05	0.00188	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CALCB—thyroid cancer	7e-05	0.00188	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—PPARG—thyroid cancer	6.97e-05	0.00187	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.95e-05	0.00186	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TSHR—thyroid cancer	6.79e-05	0.00182	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—HPGD—thyroid cancer	6.78e-05	0.00182	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.72e-05	0.0018	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PRKAR1A—thyroid cancer	6.68e-05	0.00179	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TRIM33—thyroid cancer	6.63e-05	0.00178	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.6e-05	0.00177	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—MEN1—thyroid cancer	6.39e-05	0.00171	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—SST—thyroid cancer	6.3e-05	0.00169	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—PTCH1—thyroid cancer	6.25e-05	0.00168	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	6.22e-05	0.00167	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—SST—thyroid cancer	6.16e-05	0.00165	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CALCB—thyroid cancer	6.14e-05	0.00165	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—PTCH1—thyroid cancer	6.12e-05	0.00164	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—CALCA—thyroid cancer	6.06e-05	0.00163	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TSHR—thyroid cancer	6.04e-05	0.00162	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.94e-05	0.00159	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—CALCA—thyroid cancer	5.93e-05	0.00159	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TCF7L1—thyroid cancer	5.93e-05	0.00159	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TRIM33—thyroid cancer	5.82e-05	0.00156	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TCF7L1—thyroid cancer	5.81e-05	0.00156	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTCH1—thyroid cancer	5.77e-05	0.00155	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—SST—thyroid cancer	5.72e-05	0.00153	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MINPP1—thyroid cancer	5.69e-05	0.00153	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.65e-05	0.00152	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—SST—thyroid cancer	5.6e-05	0.0015	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CALCA—thyroid cancer	5.5e-05	0.00148	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TSHR—thyroid cancer	5.48e-05	0.00147	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PRKAR1A—thyroid cancer	5.39e-05	0.00145	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CALCA—thyroid cancer	5.39e-05	0.00145	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TSHR—thyroid cancer	5.3e-05	0.00142	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—SST—thyroid cancer	5.28e-05	0.00142	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	5.23e-05	0.0014	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CALCA—thyroid cancer	5.08e-05	0.00136	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—CDK1—thyroid cancer	4.98e-05	0.00134	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TPR—thyroid cancer	4.92e-05	0.00132	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—CDK1—thyroid cancer	4.88e-05	0.00131	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PRKAR1A—thyroid cancer	4.84e-05	0.0013	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—NDUFA13—thyroid cancer	4.84e-05	0.0013	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TSHR—thyroid cancer	4.81e-05	0.00129	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—PTEN—thyroid cancer	4.78e-05	0.00128	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PRKAR1A—thyroid cancer	4.74e-05	0.00127	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—SST—thyroid cancer	4.7e-05	0.00126	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—PTCH1—thyroid cancer	4.66e-05	0.00125	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CDK1—thyroid cancer	4.6e-05	0.00123	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TPR—thyroid cancer	4.56e-05	0.00122	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CHST14—thyroid cancer	4.55e-05	0.00122	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—CALCA—thyroid cancer	4.52e-05	0.00121	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	4.5e-05	0.00121	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	4.5e-05	0.00121	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PRKAR1A—thyroid cancer	4.48e-05	0.0012	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TCF7L1—thyroid cancer	4.43e-05	0.00119	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.42e-05	0.00119	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.39e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TSHR—thyroid cancer	4.34e-05	0.00117	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PRKAR1A—thyroid cancer	4.27e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—SST—thyroid cancer	4.26e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TSHR—thyroid cancer	4.25e-05	0.00114	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TPR—thyroid cancer	4.21e-05	0.00113	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—HRAS—thyroid cancer	4.2e-05	0.00113	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PRKAR1A—thyroid cancer	4.18e-05	0.00112	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	4.16e-05	0.00112	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	4.14e-05	0.00111	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—SST—thyroid cancer	4.12e-05	0.00111	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CALCA—thyroid cancer	4.11e-05	0.0011	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—PTCH1—thyroid cancer	4.09e-05	0.0011	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—MEN1—thyroid cancer	4.08e-05	0.0011	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—MEN1—thyroid cancer	4e-05	0.00107	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—CALCA—thyroid cancer	3.97e-05	0.00106	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TPR—thyroid cancer	3.89e-05	0.00104	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TCF7L1—thyroid cancer	3.89e-05	0.00104	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PRKAR1A—thyroid cancer	3.83e-05	0.00103	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.75e-05	0.00101	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—SST—thyroid cancer	3.74e-05	0.001	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—CDK1—thyroid cancer	3.72e-05	0.000997	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NRG1—thyroid cancer	3.69e-05	0.000991	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTCH1—thyroid cancer	3.69e-05	0.000991	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SLC5A5—thyroid cancer	3.68e-05	0.000988	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—HPGD—thyroid cancer	3.67e-05	0.000983	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTCH1—thyroid cancer	3.62e-05	0.00097	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CALCA—thyroid cancer	3.6e-05	0.000967	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	3.54e-05	0.000949	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.45e-05	0.000926	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SLC5A5—thyroid cancer	3.41e-05	0.000915	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—SST—thyroid cancer	3.38e-05	0.000906	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.37e-05	0.000903	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TERT—thyroid cancer	3.32e-05	0.00089	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—SST—thyroid cancer	3.31e-05	0.000887	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—TP53—thyroid cancer	3.26e-05	0.000876	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—CDK1—thyroid cancer	3.26e-05	0.000875	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CALCA—thyroid cancer	3.25e-05	0.000872	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TSHR—thyroid cancer	3.24e-05	0.000869	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—HRAS—thyroid cancer	3.22e-05	0.000863	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	3.2e-05	0.000857	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PRKAR1A—thyroid cancer	3.19e-05	0.000855	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CALCA—thyroid cancer	3.18e-05	0.000854	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HIF1A—thyroid cancer	3.17e-05	0.000851	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	3.15e-05	0.000845	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—RXRA—thyroid cancer	3.09e-05	0.00083	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.08e-05	0.000827	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—MEN1—thyroid cancer	3.05e-05	0.000817	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.01e-05	0.000807	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.95e-05	0.000791	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CDK1—thyroid cancer	2.94e-05	0.000789	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SLC5A5—thyroid cancer	2.92e-05	0.000782	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CDK1—thyroid cancer	2.88e-05	0.000773	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—RXRA—thyroid cancer	2.87e-05	0.000769	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TSHR—thyroid cancer	2.84e-05	0.000763	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.83e-05	0.000759	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PRKAR1A—thyroid cancer	2.8e-05	0.000751	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—NRAS—thyroid cancer	2.79e-05	0.00075	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTCH1—thyroid cancer	2.75e-05	0.000739	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—MEN1—thyroid cancer	2.67e-05	0.000717	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—RXRA—thyroid cancer	2.65e-05	0.00071	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—BRAF—thyroid cancer	2.63e-05	0.000705	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.57e-05	0.00069	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—SST—thyroid cancer	2.52e-05	0.000676	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—RXRA—thyroid cancer	2.45e-05	0.000657	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CALCA—thyroid cancer	2.43e-05	0.000651	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTCH1—thyroid cancer	2.42e-05	0.000649	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—KRAS—thyroid cancer	2.41e-05	0.000645	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	2.37e-05	0.000635	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NRG1—thyroid cancer	2.36e-05	0.000634	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NRG1—thyroid cancer	2.31e-05	0.00062	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—SST—thyroid cancer	2.21e-05	0.000593	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CDK1—thyroid cancer	2.2e-05	0.000589	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CALCA—thyroid cancer	2.13e-05	0.000571	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TERT—thyroid cancer	2.12e-05	0.000569	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TPR—thyroid cancer	2.11e-05	0.000565	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.11e-05	0.000565	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TERT—thyroid cancer	2.08e-05	0.000557	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.07e-05	0.000556	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HRAS—thyroid cancer	2.04e-05	0.000548	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HIF1A—thyroid cancer	2.03e-05	0.000544	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—AKT1—thyroid cancer	1.99e-05	0.000533	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HIF1A—thyroid cancer	1.99e-05	0.000533	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PPARG—thyroid cancer	1.95e-05	0.000524	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CDK1—thyroid cancer	1.93e-05	0.000517	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—CCND1—thyroid cancer	1.92e-05	0.000514	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—PTEN—thyroid cancer	1.85e-05	0.000496	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PPARG—thyroid cancer	1.81e-05	0.000486	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—AKT1—thyroid cancer	1.81e-05	0.000484	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—NRAS—thyroid cancer	1.79e-05	0.000479	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.78e-05	0.000477	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NRG1—thyroid cancer	1.76e-05	0.000473	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—NRAS—thyroid cancer	1.75e-05	0.000469	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—BRAF—thyroid cancer	1.68e-05	0.000451	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PPARG—thyroid cancer	1.67e-05	0.000448	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—NRAS—thyroid cancer	1.65e-05	0.000443	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—BRAF—thyroid cancer	1.64e-05	0.000441	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TERT—thyroid cancer	1.58e-05	0.000424	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SLC5A5—thyroid cancer	1.58e-05	0.000423	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NRG1—thyroid cancer	1.55e-05	0.000415	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PPARG—thyroid cancer	1.55e-05	0.000415	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—KRAS—thyroid cancer	1.54e-05	0.000413	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTGS2—thyroid cancer	1.54e-05	0.000412	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HIF1A—thyroid cancer	1.51e-05	0.000406	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—KRAS—thyroid cancer	1.51e-05	0.000404	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTGS2—thyroid cancer	1.42e-05	0.000382	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—KRAS—thyroid cancer	1.42e-05	0.000381	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TERT—thyroid cancer	1.39e-05	0.000373	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—PTEN—thyroid cancer	1.34e-05	0.000359	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—NRAS—thyroid cancer	1.33e-05	0.000358	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HIF1A—thyroid cancer	1.33e-05	0.000356	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—RXRA—thyroid cancer	1.32e-05	0.000355	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.31e-05	0.000352	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRAS—thyroid cancer	1.31e-05	0.000351	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRAS—thyroid cancer	1.28e-05	0.000343	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—AKT1—thyroid cancer	1.27e-05	0.000341	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TP53—thyroid cancer	1.26e-05	0.000339	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—BRAF—thyroid cancer	1.25e-05	0.000336	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—AKT1—thyroid cancer	1.24e-05	0.000334	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—PTEN—thyroid cancer	1.24e-05	0.000333	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—CCND1—thyroid cancer	1.23e-05	0.000329	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTGS2—thyroid cancer	1.22e-05	0.000326	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRAS—thyroid cancer	1.21e-05	0.000324	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—CCND1—thyroid cancer	1.2e-05	0.000322	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—PTEN—thyroid cancer	1.18e-05	0.000317	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—NRAS—thyroid cancer	1.17e-05	0.000314	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—PTEN—thyroid cancer	1.16e-05	0.000311	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—AKT1—thyroid cancer	1.15e-05	0.00031	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—KRAS—thyroid cancer	1.15e-05	0.000308	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.15e-05	0.000307	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—AKT1—thyroid cancer	1.13e-05	0.000303	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—BRAF—thyroid cancer	1.1e-05	0.000295	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKT1—thyroid cancer	1.07e-05	0.000286	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—PTEN—thyroid cancer	1.06e-05	0.000285	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—NRAS—thyroid cancer	1.06e-05	0.000283	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	0.000277	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—KRAS—thyroid cancer	1.01e-05	0.00027	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRAS—thyroid cancer	9.75e-06	0.000262	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—AKT1—thyroid cancer	9.48e-06	0.000254	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—CCND1—thyroid cancer	9.14e-06	0.000245	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—KRAS—thyroid cancer	9.09e-06	0.000244	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—KRAS—thyroid cancer	8.9e-06	0.000239	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—PTEN—thyroid cancer	8.83e-06	0.000237	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—AKT1—thyroid cancer	8.61e-06	0.000231	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRAS—thyroid cancer	8.56e-06	0.00023	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PPARG—thyroid cancer	8.36e-06	0.000224	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—AKT1—thyroid cancer	8.32e-06	0.000223	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TP53—thyroid cancer	8.07e-06	0.000217	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—CCND1—thyroid cancer	8.03e-06	0.000215	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TP53—thyroid cancer	7.91e-06	0.000212	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—NRAS—thyroid cancer	7.87e-06	0.000211	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—PTEN—thyroid cancer	7.75e-06	0.000208	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRAS—thyroid cancer	7.72e-06	0.000207	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—AKT1—thyroid cancer	7.72e-06	0.000207	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRAS—thyroid cancer	7.56e-06	0.000203	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—AKT1—thyroid cancer	7.56e-06	0.000203	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—AKT1—thyroid cancer	7.16e-06	0.000192	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—NRAS—thyroid cancer	6.91e-06	0.000185	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKT1—thyroid cancer	6.82e-06	0.000183	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—KRAS—thyroid cancer	6.78e-06	0.000182	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKT1—thyroid cancer	6.68e-06	0.000179	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—AKT1—thyroid cancer	6.6e-06	0.000177	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTGS2—thyroid cancer	6.58e-06	0.000176	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—AKT1—thyroid cancer	6.11e-06	0.000164	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TP53—thyroid cancer	6.02e-06	0.000162	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—KRAS—thyroid cancer	5.95e-06	0.00016	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRAS—thyroid cancer	5.76e-06	0.000155	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—PTEN—thyroid cancer	5.74e-06	0.000154	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TP53—thyroid cancer	5.29e-06	0.000142	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKT1—thyroid cancer	5.09e-06	0.000136	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRAS—thyroid cancer	5.06e-06	0.000136	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKT1—thyroid cancer	4.47e-06	0.00012	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—AKT1—thyroid cancer	3.31e-06	8.87e-05	CbGpPWpGaD
